Cytosorbents (CTSO) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.58% |
| Dec 31, 2025 | 29.84% |
| Sep 30, 2025 | 31.58% |
| Jun 30, 2025 | 34.10% |
| Mar 31, 2025 | 34.34% |
| Dec 31, 2024 | 36.13% |
| Sep 30, 2024 | 37.05% |
| Jun 30, 2024 | 37.41% |
| Mar 31, 2024 | 38.74% |
| Dec 31, 2023 | 42.20% |
| Sep 30, 2023 | 43.72% |
| Jun 30, 2023 | 42.78% |
| Mar 31, 2023 | 46.07% |
| Dec 31, 2022 | 50.25% |
| Sep 30, 2022 | 59.65% |
| Jun 30, 2022 | 69.75% |
| Mar 31, 2022 | 67.89% |
| Dec 31, 2021 | 55.34% |
| Sep 30, 2021 | 43.51% |
| Jun 30, 2021 | 38.52% |
| Mar 31, 2021 | 33.40% |
| Dec 31, 2020 | 30.63% |
| Dec 31, 2019 | 50.93% |
| Sep 30, 2019 | 58.59% |
| Jun 30, 2019 | 62.08% |
| Mar 31, 2019 | 64.93% |
| Dec 31, 2018 | 64.32% |
| Sep 30, 2018 | 63.50% |
| Jun 30, 2018 | 65.46% |
| Mar 31, 2018 | 63.00% |
| Dec 31, 2017 | 57.31% |
| Sep 30, 2017 | 50.33% |
| Jun 30, 2017 | 38.47% |
| Mar 31, 2017 | 31.75% |
| Dec 31, 2016 | 29.71% |
| Sep 30, 2016 | 33.98% |
| Jun 30, 2016 | 33.95% |
| Dec 31, 2015 | 31.06% |